This page lists the SEC filings reported by Wildcat Capital Management, LLC.
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G | 2024-04-08 | Wildcat Capital Management, LLC | Frontier Group Holdings, Inc. | 28,061,351 | 12.6% | EDGAR |
| SC 13D/A | 2023-01-05 | Wildcat Capital Management, LLC | Skillz Inc. | 19,596,988 | 5.6% | EDGAR |
| SC 13G/A | 2022-02-14 | Wildcat Capital Management, LLC | UroGen Pharma Ltd. | 533,139 | 2.4% | EDGAR |
| SC 13D/A | 2021-03-23 | Wildcat Capital Management, LLC | Skillz Inc. | 21,265,819 | 6.7% | EDGAR |
| SC 13D/A | 2021-03-08 | Wildcat Capital Management, LLC | Skillz Inc. | 21,832,022 | 7.5% | EDGAR |
| SC 13G/A | 2021-02-12 | Wildcat Capital Management, LLC | UroGen Pharma Ltd. | 533,139 | 2.4% | EDGAR |
| SC 13D/A | 2020-12-31 | Wildcat Capital Management, LLC | Skillz Inc. | 21,433,040 | 7.3% | EDGAR |
| SC 13D | 2020-12-28 | Wildcat Capital Management, LLC | Skillz Inc. | 21,433,050 | 7.3% | EDGAR |
| SC 13G/A | 2020-02-14 | Wildcat Capital Management, LLC | UroGen Pharma Ltd. | 533,139 | 2.5% | EDGAR |
| SC 13G | 2019-10-04 | Wildcat Capital Management, LLC | UroGen Pharma Ltd. | 533,139 | 2.6% | EDGAR |
| SC 13G/A | 2018-02-13 | Wildcat Capital Management, LLC | Sorrento Therapeutics, Inc. | 1,738,232 | 2.2% | EDGAR |
| SC 13G/A | 2018-02-13 | Wildcat Capital Management, LLC | NantKwest, Inc. | 808,974 | 1.0% | EDGAR |
| SC 13G | 2017-02-14 | Wildcat Capital Management, LLC | Sorrento Therapeutics, Inc. | 2,676,193 | 5.3% | EDGAR |
| SC 13D/A | 2016-06-22 | Wildcat Capital Management, LLC | Sorrento Therapeutics, Inc. | 2,676,193 | 4.1% | EDGAR |
| SC 13D/A | 2016-06-02 | Wildcat Capital Management, LLC | Sorrento Therapeutics, Inc. | 2,676,193 | 6.7% | EDGAR |
| SC 13D/A | 2016-05-16 | Wildcat Capital Management, LLC | Sorrento Therapeutics, Inc. | 2,676,193 | 6.7% | EDGAR |
| SC 13D/A | 2016-05-11 | Wildcat Capital Management, LLC | Sorrento Therapeutics, Inc. | 2,676,193 | 6.7% | EDGAR |
| SC 13D/A | 2016-05-06 | Wildcat Capital Management, LLC | Sorrento Therapeutics, Inc. | 2,499,936 | 6.5% | EDGAR |
| SC 13D/A | 2016-04-26 | Wildcat Capital Management, LLC | Sorrento Therapeutics, Inc. | 2,499,936 | 6.5% | EDGAR |
| SC 13D | 2016-04-18 | Wildcat Capital Management, LLC | Sorrento Therapeutics, Inc. | 2,499,936 | 6.5% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.